特里普托利德通过抑制2组先天性淋巴细胞功能来缓解过敏呼吸道炎症
Chenghua Yan1, Wendong Kuang2, Xinsheng Liu3
1College of Traditional Chinese Medicine/College of Life Sciences, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
International immunopharmacology
|January 7, 2025
概括
传统中医药中的三类,通过抑制2组先天性淋巴细胞 (ILC2s),有效降低过敏气道炎症. 这项研究强调了三托利德.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
背景情况:
- 2组先天性淋巴细胞 (ILC2s) 是2型免疫反应的关键参与者,包括过敏呼吸道炎症.
- 洲际蛋白-33 (IL-33) 是激活ILC2s的一个关键细胞因子.
- 针对肺部ILC2s使用特定药物,特别是来自传统中医药的药物,仍未得到充分研究.
研究的目的:
- 调查传统中医药的三胺在改善过敏呼吸道炎症方面的潜力.
- 阐明ptolide 影响 ILC2 激活和功能的机制.
- 探索三类对过敏呼吸道疾病的治疗潜力.
主要方法:
- 利用过敏气道炎症的实验模型.
- 用于评估其对ILC2s和炎症的影响.
- 进行RNA测序 (RNA-seq) 来分析ILC2s中的基因表达变化.
- 挑战用IL-33治疗的ILC2s与IL-33一起评估功能障碍.
主要成果:
- 特里普托利德显著改善了过敏性气道炎症.
- 特里普托利德抑制了IL-33.3对IL的反应中ILC2s的激活和功能.
- RNA-seq分析揭示了triptolide对与炎症相关的信号通路和ILC2相关的基因表达 (例如IL-5,IL-13) 的影响.
- 特里普托利德证明了预防和治疗效果.
结论:
- 特里普托利德有效抑制ILC2的激活,从而改善过敏气道炎症.
- ptolide调节关键的与炎症相关的信号通路和ILC2s中的基因表达.
- 特里普托利德作为治疗过敏呼吸道炎症的治疗剂具有前景,准ILC2s.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:27Allergic Drug Reactions
809
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
809
01:24T Cell Types and Functions
946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946